← Eichor
Condition: Beta Lactam Resistant Bacterial Infection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Beta Lactam Resistant Bacterial Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa
Phase N/A · 48 location(s) · Centre Hospitalier Régional d'Orléans · NCT06738771PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enter
Phase 4 · 14 location(s) · Rambam Health Care Campus · NCT03671967
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.